cGMP-Dependent Protein Kinase I and Smooth Muscle Relaxation
Authors: Howard K. Surks
Journal: Circulation Research (2007)

HomeCirculation ResearchVol. 101, No. 11cGMP-Dependent Protein Kinase I and Smooth Muscle Relaxation Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBcGMP-Dependent Protein Kinase I and Smooth Muscle RelaxationA Tale of Two Isoforms Howard K. Surks Howard K. SurksHoward K. Surks From the Tufts-New England Medical Center, Boston, Mass. Originally published26 Nov 2007https://doi.org/10.1161/CIRCRESAHA.107.165779Circulation Research. 2007;101:1078–1080The maintenance of vascular tone is central to the regulation of blood pressure and tissue perfusion and plays a role in the pathogenesis of hypertension and atherosclerosis. Vascular tone is determined by the balance of vasodilator and vasoconstrictor stimuli. After several decades of research, the NO/cGMP/cGMP-dependent protein kinase (cGK) pathway is now recognized as an important mediator of vasodilation. However, the mechanisms by which cGK causes smooth muscle relaxation continue to be an important question.Smooth muscle contraction and relaxation are tightly coupled to the phosphorylation and dephosphorylation, respectively, of the regulatory myosin light chain.1 Myosin light chain phosphorylation state is determined by the relative activities of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP). MLCK phosphorylates MLC leading to contraction,2 and MLCP dephosphorylates MLC, leading to relaxation3 (Figure). Both MLCK and MLCP activities are highly regulated. MLCK activity is activated by the binding of calcium/calmodulin and thus is the primary mechanism linking intracellular calcium concentration to smooth muscle contractility.4 MLCP activity is regulated by both vasodilator and vasoconstrictor stimuli, and is therefore responsible for much of the calcium-independent regulation of contractility (reviewed in5). Download figureDownload PowerPointFigure. MLC phosphorylation determines smooth muscle contractility. Contractile agonists lead to inositol 1,4,5 triphosphate (IP3) production or activation of RhoA (RhoA-GTP). IP3 binding to its receptor in the sarcoplasmic reticulum leads to release of Ca2+. Ca2+/calmodulin binds to and activates MLCK, which in turn phosphorylates MLC (calcium-dependent contraction). Activated RhoA binds to and activates ROCK, leading to phosphorylation and inhibition of MLCP, inhibiting MLC dephosphorylation (calcium-independent contraction). cGKI mediates relaxation by inhibiting both calcium-dependent and -independent contraction. cGKIα activates MLCP by a direct interaction and by inhibition of RhoA, and activates RGS2 to inhibit Gαq signaling. cGKIβ activates IRAG, which then inhibits Ca2+ release by the IP3 receptor.cGK mediates vasorelaxation by both calcium-dependent and calcium-independent pathways. Initial experiments found that cGMP inhibited calcium elevations in freshly isolated aortic smooth muscle cells. However, in passaged aortic smooth muscle cells in which cGK expression is downregulated, cGMP failed to inhibit calcium elevations, supporting that cGK mediated smooth muscle relaxation, in part, results from the inhibition of intracellular calcium mobilization.6 In permeabilized smooth muscle strips in which transmembrane calcium concentrations can be clamped without loss of intracellular proteins, cGMP induces smooth muscle relaxation without a change in intracellular calcium, suggesting that cGK could mediate calcium-independent relaxation via activation of MLCP.7,8 Perhaps the most definitive evidence to date comes from the complete cGKI knockout mouse model. These mice have multiple cardiovascular, gastrointestinal, hematopoietic, and neurological abnormalities, resulting in early postnatal mortality and making them difficult to study. Nevertheless, the aortas from these mice failed to relax after stimulation of the NO/cGMP/cGK pathway, supporting a critical role for cGKI in vascular relaxation.9The cGK family includes two distinct genes, prkg1 and prkg2, that encode cGKI and cGKII, respectively.10 cGKI is the isoform expressed in smooth muscle tissues.11 The amino terminus of cGKI is encoded by two alternatively spliced exons, resulting in the two isoforms cGKIα and cGKIβ, that differ only in the amino-terminal leucine zipper domains.10 Several studies have shown that both cGKI isoforms are expressed in smooth muscle, raising the question whether one or both isoforms are responsible for smooth muscle relaxation, which is addressed by Weber et al in this issue of Circulation Research.12In recent years, molecular studies have contributed to the hypothesis that both cGKI isoforms contribute to smooth muscle relaxation and are targeted to specific substrates via their amino-terminal leucine zipper domains. In a screen for cGKIα interacting proteins, our laboratory found that cGK1α interacts directly with the regulatory myosin binding subunit (MYPT1) of MLCP. This interaction targets cGKIα to MLCP and is critical for cGKI-mediated activation of MLCP.13 Although MYPT1 was originally thought to target MLCP to contractile fibers, we found that targeting of MLCP is more complex and involves a molecular scaffold, myosin phosphatase-rho interacting protein, that anchors MLCP to actin and colocalizes RhoA to regulate MLCP.14–16 Tang et al demonstrated that cGKIα inhibits thrombin receptor-mediated calcium release through a cGKIα-regulator of G protein signaling (RGS)2 interaction. This leucine zipper-mediated interaction targets cGKIα to phosphorylate and activate RGS2, which in turn increases the GTPase activity of Gαq, terminating thrombin receptor signaling.17 cGKIβ was found to regulate inositol 1,4,5 triphosphate (IP3)-mediated calcium release by binding to and phosphorylating the inositol 1,4,5-triphosphate receptor-associated cGMP kinase substrate (IRAG). The cGKIβ-IRAG interaction leads to phosphorylation of IRAG and inhibition of calcium release via the inositol triphosphate type I receptor.18 These isoform-specific leucine zipper-mediated interactions have formed the basis of a targeting hypothesis in which both cGKI isoforms have distinct functional roles in smooth muscle relaxation by virtue of their specific targets (Figure).Previous approaches have used cell culture models to test the targeting hypothesis. In one study, GFP-tagged cGKIα or cGKIβ were transfected into cGKI-null smooth muscle cells and tested for inhibition of calcium release. Only the cGKIα-containing cells exhibited calcium regulation by cGMP.19 A potential limitation in this study is the possibility that the GFP moiety interfered with cGKI targeting. In a recent study by Christensen and Mendelsohn, the role of PKGI isoforms in thrombin receptor-mediated calcium mobilization was studied in both CHO cells stably expressing either cGKI isoform and human aortic smooth muscle cells expressing primarily cGKIα or cGKIβ. In CHO cells, cGKIα had a significantly greater calcium-lowering effect, whereas in cultured human aorta smooth muscle cells, only cGKIα lowered calcium in response to cGMP.20 Thus neither of these cell culture-based studies that manipulated the expression of cGKI isoforms confirmed the expected isoform-specific functions based on cGKI targeting.In the current study, Weber et al took the interesting approach of creating mouse lines that express either cGKIα or cGKIβ on a cGKI null background. Expression of the cGKI genes was driven by the endogenous SM22α promoter, resulting in smooth muscle–specific expression. The cGKI isoforms were expressed at levels and activity 1.5- to 2.0-fold greater than control mice. The transgenic rescue mice had a life expectancy greater than the cGKI null mice, but less than the wild-type control mice. Interestingly, all of the tested smooth muscle functions in the cGKI transgenics were equivalent to those in the wild-type mice. These included intestinal transit of barium, jejunal, and aortic smooth muscle relaxation and inhibition of norepinephrine-induced calcium transients by cGMP. Although surprising, these data could still be explained by the known interactions between cGKIα and cGKIβ with RGS2 and IRAG, respectively.Weber et al performed a thorough examination of blood pressure in the null, wild-type, and the cGKIα and cGKIβ rescue mice. The basal blood pressure was not different between wild-type and rescue mice, but was elevated as expected in the cGKI-null mice. Moreover, the hypotensive effect of nitrovasodilators, carbachol, and the ROCK inhibitor Y27632 were all preserved in the cGKI rescue mice. The latter manipulation is particularly interesting because cGKIα opposes the inhibitory effect of RhoA/ROCK on MLCP activity and inhibits RhoA directly by phosphorylation at Ser188.21 One would therefore expect that the cGKIα rescue mice would have less RhoA/ROCK activity and therefore less hypotension from Y27632.The elegant approach by Weber et al avoids many of the pitfalls of the earlier studies of cGKI isoform-specific functions in the vasculature, including reliance on cell culture models and use of epitope-tagged cGKI isoforms. How then can we explain the apparently equivalent physiologic effect of cGKIα and cGKIβ rescue? The authors provide two hypotheses. First, it is possible that the specificity for each isoform for their respective targets is less pronounced in vivo. This is possible because most of the experiments that characterized the cGKI isoform specific targets were performed in cell culture systems and with purified proteins. If there were more overlap between cGKI isoforms and their target interactions, then expression of individual cGKI isoforms might exhibit subtle, if any, differences from wild-type mice. Second, each cGKI isoform alone is sufficient to maintain circulatory physiology based on its known interactions. For example, cGKIα rescue can mediate cGMP-mediated vasodilation because it can lower calcium via its interaction with RGS2, and activate MLCP via its interaction with MYPT1. It is more difficult to reconcile how cGKIβ rescue can fully reconstitute cGMP-mediated vasodilation without regulating MLCP.There are several additional possibilities that may explain the apparent functional equivalence of cGKIα and cGKIβ to rescue vascular function. The cGKI targets discussed here have well-described isoform-specific interactions, yet there are additional cGKI targets that do not bind in an isoform specific manner, whose role in vascular physiology is less clear, and there are likely more targets that are undiscovered.22,23 These cGKI targets may allow functional overlap between the cGKI isoforms. Furthermore, although Weber et al observed similar expression of the cGKI isoform targets, IRAG, MYPT1, and RhoA, other critical proteins within these signaling pathways may be upregulated. Moreover, posttranslational modification (eg, phosphorylation) of these isoform-specific targets or splice variation may also contribute to altered activity of these signaling pathways without apparent differences in their protein expression levels. A third possibility represents a limitation to any transgenic approach when used to explore pathways regulated by differential targeting. Even modestly increased levels of protein overexpression may be adequate to obscure the specificity of protein targeting, particularly if the protein in question is present in excess of the targeting protein.Future experiments with this model may provide important insights into cGKI isoform specificity. Biochemical experiments comparing wild-type, null, and rescue mouse vascular tissue for isoform-specific binding to respective targets and regulation of these pathways would be revealing. For example, is there cGMP-mediated activation of MLCP and phosphorylation/inhibition of RhoA in both cGKI isoform rescue mice? Can cGMP induce cGKI interaction with and phosphorylation of IRAG in both rescue mice?Ultimately, additional genetic models in mice may be the best approach. Among these, inducible, tissue-specific deletion of each cGKI isoform will provide the opportunity to dissect their roles in vascular function while avoiding any concerns about loss of specificity in cGKI overexpression mice. Finally, specific knock-in mutations to disrupt cGKI isoform targeting will also be informative. Our laboratory has created a mouse in which the leucines and isoleucines in the cGKIα leucine zipper domain have been mutated to alanine, disrupting its interaction with MLCP without affecting kinase activity. Preliminary studies show that these mice are hypertensive and have abnormalities of vascular relaxation, supporting the isoform specific targeting hypothesis and the importance of cGKIα in the regulation of vascular tone.24cGKI is critical for the maintenance of vascular tone by mediating vasodilation in response to nitrovasodilators. The two cGKI isoforms interact with specific targets in smooth muscle via their amino-terminal leucine zipper domains, and there is debate about their relative roles in smooth muscle relaxation. This carefully performed, elegant study by Weber et al adds an interesting wrinkle to the targeting hypothesis by showing that both cGKIα and cGKIβ can rescue vascular relaxation and intestinal motility in cGKI null mice. Future biochemical studies with this model, as well as additional genetic targeting approaches to delete or mutate specific cGKI isoforms, will provide a wealth of information about these pathways in the near future.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.The author thanks Richard Patten and Akiko Hata for critical review of the manuscript.Sources of FundingThe author is supported by National Institutes of Health grants HL074069 and HL077378.DisclosuresNone.FootnotesCorrespondence to Howard K. Surks, Tufts-New England Med Center, Molecular Cardiology Research Institute, 750 Washington St, Box 80, Boston, MA 02111. E-mail [email protected] References 1 Hartshorne DJ. Biochemistry of the contractile process in smooth muscle. In: Physiology of the Gastrointestinal Tract. Johnson DR, ed. 1987. Raven, New York.Google Scholar2 Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Ann Rev Pharmacol Toxicol. 1985; 25: 593.CrossrefMedlineGoogle Scholar3 Alessi D, MacDougall LK, Sola MM, Ikebe M, Cohen P. The control of protein phosphatase-1 by targetting subunits. Eur J Biochem. 1992; 210: 1023–1035.CrossrefMedlineGoogle Scholar4 Taylor DA, Stull JT. Calcium Dependence of Myosin Light Chain Phosphorylation in Smooth Muscle Cells. J Biol Chem. 1988; 263: 14456–14462.CrossrefMedlineGoogle Scholar5 Hartshorne DJ, Ito M, Erdodi F. Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J Biol Chem. 2004; 279 (36): 37211–37214.CrossrefMedlineGoogle Scholar6 Cornwell TL, Lincoln TM. Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells: reduction of Ca2+ by atriopeptin and 8-bromo-cGMP is mediated by cGMP-dependent protein kinase. J Biol Chem. 1989; 264: 1146–1155.CrossrefMedlineGoogle Scholar7 Lee MR, Li L, Kitazawa T. Cyclic GMP causes Ca+2 desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem. 1997; 272: 5063–5068.CrossrefMedlineGoogle Scholar8 Wu X, Somlyo AV, Somlyo AP. Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphatase. Biochem Biophys Res Com. 1996; 220: 658–663.CrossrefMedlineGoogle Scholar9 Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneil C, Wang G-X, Korth M, Aszodi A, Andersson K-E, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F. Defective smooth muscle regulation in cGMP kinase 1-deficient mice. EMBO J. 1998; 17: 3045–3051.CrossrefMedlineGoogle Scholar10 Orstavik S, Natarajan V, Tasken K, Jahnsen T, Sandberg M. Characterization of the human gene encoding the type 1alpha and type 1beta cGMP-dependent protein kinase (PRKG1). Genomics. 1997; 42: 311–318.CrossrefMedlineGoogle Scholar11 Tamura N, Itoh H, Ogawa Y, Nakagawa O, Harada M, Chun T-H, Suga S, Yoshimasa T, Nakao K. cDNA cloning and gene expression of human type 1 alpha cGMP-dependent protein kinase. Hypertension. 1996; 27: 552–557.CrossrefMedlineGoogle Scholar12 Weber S, Bernhard D, Lukowski R, Weinmeister P, Worner R, Wegener JW, Valtcheva N, Feil S, Schlossmann J, Hofmann F, Feil R. Rescue of cGMP kinase I knockout mice by smooth muscle-specific expression of either isozyme. Circ Res. 2007; 101: 1096–1103.LinkGoogle Scholar13 Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, Mendelsohn ME. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase 1 alpha. Science. 1999; 286: 1583–1587.CrossrefMedlineGoogle Scholar14 Surks HK, Richards CT, Mendelsohn ME. Myosin phosphatase-Rho interacting protein: a new member of the myosin phosphatase complex that directly binds RhoA. J Biol Chem. 2003; 278: 51484–51493.CrossrefMedlineGoogle Scholar15 Surks HK, Riddick N, Ohtani K. M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells. J Biol Chem. 2005; 280: 42543–42551.CrossrefMedlineGoogle Scholar16 Riddick N, Ohtani K, Surks HK. Targeting by myosin phosphatase-Rho interacting protein mediates RhoA/ROCK regulation of myosin phosphatase. J Cell Biochem. In press.Google Scholar17 Tang KM, Wang G-R, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, Mendelsohn ME. Regulator of G-protein signaling 2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med. 2003; 9 (12): 1506–1512.CrossrefMedlineGoogle Scholar18 Schlossmann J, Ammendola A, Ashman K, Zong X, Huber A, Neubauer G, Wang G-X, Allescher H-D, Korth M, Wilm M, Hofmann F, Ruth P. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase 1B. Nature. 2000; 404: 197–201.CrossrefMedlineGoogle Scholar19 Feil R, Gappa N, Rutz M, Schlossmann J, Rose CR, Konnerth A, Brummer S, Kuhbandner S, Hofmann F. Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase I isoforms. Circ Res. 2002; 90: 1080–1086.LinkGoogle Scholar20 Christensen EN, Mendelsohn ME. Cyclic GMP-dependent protein kinase I alpha Inhibits Thrombin Receptor-mediated calcium mobilization in vascular smooth muscle cells. J Biol Chem. 2006; 281: 8409–8416.CrossrefMedlineGoogle Scholar21 Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann S, Bertoglio J, Chardin P, Pacaud P, Loirand G. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced calcium sensitization of contraction in vascular smooth muscle. J Biol Chem. 2000; 275: 21722–21729.CrossrefMedlineGoogle Scholar22 Zhang T, Zhuang S, Casteel DE, Looney DJ, Boss GR, Pilz RB. A cysteine-rich LIM-only protein mediates regulation of smooth muscle-specific gene expression by cGMP-dependent protein kinase. J Biol Chem. 2007; Papers In Press Sept. 18.Google Scholar23 Yuasa K, Michibata H, Omori K, Yanaka N. A novel interaction of cGMP-dependent protein kinase 1 with troponin T. J Biol Chem. 1999; 274: 37429–37434.CrossrefMedlineGoogle Scholar24 Mendelsohn ME. Regulation of vascular smooth muscle cell phenotype, vascular function and blood pressure by cyclic GMP-dependent protein Kinase 1 alpha. Keystone Symposia, Molecular Biology of the Vasculature, April 5, 2006.Google Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Rachubik P, Szrejder M, Rogacka D, Typiak M, Audzeyenka I, Kasztan M, Pollock D, Angielski S and Piwkowska A (2022) Insulin controls cytoskeleton reorganization and filtration barrier permeability via the PKGIα-Rac1-RhoA crosstalk in cultured rat podocytes, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 10.1016/j.bbamcr.2022.119301, 1869:9, (119301), Online publication date: 1-Sep-2022. Friebe A and Englert N (2021) NO‐sensitive guanylyl cyclase in the lung, British Journal of Pharmacology, 10.1111/bph.15345, 179:11, (2328-2343), Online publication date: 1-Jun-2022. Tettey A, Jiang Y, Li X and Li Y (2021) Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway, Frontiers in Pharmacology, 10.3389/fphar.2021.767002, 12 Längst N, Adler J, Schweigert O, Kleusberg F, Cruz Santos M, Knauer A, Sausbier M, Zeller T, Ruth P and Lukowski R (2021) Cyclic GMP-Dependent Regulation of Vascular Tone and Blood Pressure Involves Cysteine-Rich LIM-Only Protein 4 (CRP4), International Journal of Molecular Sciences, 10.3390/ijms22189925, 22:18, (9925) Omotayo M, Abioye A, Kuyebi M and Eke A (2021) Prenatal anemia and postpartum hemorrhage risk: A systematic review and meta‐analysis, Journal of Obstetrics and Gynaecology Research, 10.1111/jog.14834, 47:8, (2565-2576), Online publication date: 1-Aug-2021. Wong M, Yi C, Liu T, Lei W, Hung J, Liu C and Chen C (2020) Effects of phosphodiesterase‐5 inhibitor sildenafil on esophageal secondary peristalsis: Studies with high‐resolution manometry, Journal of Gastroenterology and Hepatology, 10.1111/jgh.15170, 36:2, (430-435), Online publication date: 1-Feb-2021. Sherikar A, Dhavale R and Bhatia M Vasorelaxant Effect of Novel Nitric Oxide-Hydrogen Sulfide Donor Chalcone in Isolated Rat Aorta: Involvement of cGMP Mediated sGC and Potassium Channel Activation, Current Molecular Pharmacology, 10.2174/1874467212666191025092346, 13:2, (126-136) Schwemer T, Deutscher N, Diermann N, Böger R, Schwedhelm E, Blankenberg S and Friedrich F (2019) Effect of ranolazine on plasma arginine derivatives and urinary isoprostane 8-iso-PGF2α in patients with myocardial infarction in the randomized RIMINI-Trial, Scientific Reports, 10.1038/s41598-019-42239-1, 9:1, Online publication date: 1-Dec-2019. Vajana E, Barbato M, Colli L, Milanesi M, Rochat E, Fabrizi E, Mukasa C, Del Corvo M, Masembe C, Muwanika V, Kabi F, Sonstegard T, Huson H, Negrini R, Joost S and Ajmone-Marsan P (2018) Combining Landscape Genomics and Ecological Modelling to Investigate Local Adaptation of Indigenous Ugandan Cattle to East Coast Fever, Frontiers in Genetics, 10.3389/fgene.2018.00385, 9 Carbone F and Tack J (2018) The effect of sildenafil on gastric motility and satiation in healthy controls, United European Gastroenterology Journal, 10.1177/2050640618766933, 6:6, (846-854), Online publication date: 1-Jul-2018. Lehners M, Dobrowinski H, Feil S and Feil R (2018) cGMP Signaling and Vascular Smooth Muscle Cell Plasticity, Journal of Cardiovascular Development and Disease, 10.3390/jcdd5020020, 5:2, (20) Rogacka D, Audzeyenka I, Rachubik P, Rychłowski M, Kasztan M, Jankowski M, Angielski S and Piwkowska A (2017) Insulin increases filtration barrier permeability via TRPC6-dependent activation of PKGIα signaling pathways, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 10.1016/j.bbadis.2017.03.002, 1863:6, (1312-1325), Online publication date: 1-Jun-2017. Sharma A, Birrane G, Anklin C, Rigby A and Alper S (2017) NMR insight into myosin-binding subunit coiled-coil structure reveals binding interface with protein kinase G-Iα leucine zipper in vascular function, Journal of Biological Chemistry, 10.1074/jbc.M117.781260, 292:17, (7052-7065), Online publication date: 1-Apr-2017. Verstraeten A, Luyckx I and Loeys B (2017) Aetiology and management of hereditary aortopathy, Nature Reviews Cardiology, 10.1038/nrcardio.2016.211, 14:4, (197-208), Online publication date: 1-Apr-2017. Liu N, Siu K, Youn J and Cai H (2016) Attenuation of neointimal formation with netrin-1 and netrin-1 preconditioned endothelial progenitor cells, Journal of Molecular Medicine, 10.1007/s00109-016-1490-4, 95:3, (335-348), Online publication date: 1-Mar-2017. Milewicz D, Trybus K, Guo D, Sweeney H, Regalado E, Kamm K and Stull J (2016) Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections, Arteriosclerosis, Thrombosis, and Vascular Biology, 37:1, (26-34), Online publication date: 1-Jan-2017. Klinger J (2016) Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension?, European Respiratory Journal, 10.1183/13993003.01542-2016, 48:5, (1265-1267), Online publication date: 1-Nov-2016. Piwkowska A, Rogacka D, Audzeyenka I, Kasztan M, Angielski S and Jankowski M (2016) Intracellular calcium signaling regulates glomerular filtration barrier permeability: the role of the PKGIα-dependent pathway, FEBS Letters, 10.1002/1873-3468.12228, 590:12, (1739-1748), Online publication date: 1-Jun-2016. Akashi S, Ahmed K, Sawa T, Ono K, Tsutsuki H, Burgoyne J, Ida T, Horio E, Prysyazhna O, Oike Y, Rahaman M, Eaton P, Fujii S and Akaike T (2016) Persistent Activation of cGMP-Dependent Protein Kinase by a Nitrated Cyclic Nucleotide via Site Specific Protein S -Guanylation , Biochemistry, 10.1021/acs.biochem.5b00774, 55:5, (751-761), Online publication date: 9-Feb-2016. Mitsui R and Hashitani H (2015) Mechanisms underlying spontaneous constrictions of postcapillary venules in the rat stomach, Pflügers Archiv - European Journal of Physiology, 10.1007/s00424-015-1752-y, 468:2, (279-291), Online publication date: 1-Feb-2016. Ghantous C, Azrak Z, Rahman F, Itani H and Zeidan A (2016) Assessment of Basilar Artery Reactivity in Stroke and Subarachnoid Hemorrhage Using Wire Myograph Injury Models of the Central Nervous System, 10.1007/978-1-4939-3816-2_34, (625-643), . Piwkowska A, Rogacka D, Audzeyenka I, Kasztan M, Angielski S and Jankowski M (2015) Insulin increases glomerular filtration barrier permeability through PKGIα-dependent mobilization of BKCa channels in cultured rat podocytes, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 10.1016/j.bbadis.2015.04.024, 1852:8, (1599-1609), Online publication date: 1-Aug-2015. Lee D, Park H, Lee U, Lee K, Noh E, Jang J and Kang D (2015) The effects of brain wave vibration on oxidative stress response and psychological symptoms, Comprehensive Psychiatry, 10.1016/j.comppsych.2015.03.003, 60, (99-104), Online publication date: 1-Jul-2015. Sun B, Hu C, Fang H, Zhu L, Gao N, Zhu J and Hu W (2015) The Effects of Lactobacillus acidophilus on the Intestinal Smooth Muscle Contraction through PKC/MLCK/MLC Signaling Pathway in TBI Mouse Model, PLOS ONE, 10.1371/journal.pone.0128214, 10:6, (e0128214) Lafarga T and Hayes M (2014) Bioactive peptides from meat muscle and by-products: generation, functionality and application as functional ingredients, Meat Science, 10.1016/j.meatsci.2014.05.036, 98:2, (227-239), Online publication date: 1-Oct-2014. Vitiello L, Spoletini I, Gorini S, Pontecorvo L, Ferrari D, Ferraro E, Stabile E, Caprio M and la Sala A (2014) Microvascular inflammation in atherosclerosis, IJC Metabolic & Endocrine, 10.1016/j.ijcme.2014.03.002, 3, (1-7), Online publication date: 1-Jun-2014. Denniff M, Turrell H, Vanezis A and Rodrigo G (2014) The time-of-day variation in vascular smooth muscle contractility depends on a nitric oxide signalling pathway, Journal of Molecular and Cellular Cardiology, 10.1016/j.yjmcc.2013.11.009, 66, (133-140), Online publication date: 1-Jan-2014. Bretón-Romero R and Lamas S (2014) Hydrogen peroxide signaling in vascular endothelial cells, Redox Biology, 10.1016/j.redox.2014.02.005, 2, (529-534), . Sullivan M and Earley S (2013) TRP channel Ca 2+ sparklets: fundamental signals underlying endothelium-dependent hyperpolarization , American Journal of Physiology-Cell Physiology, 10.1152/ajpcell.00273.2013, 305:10, (C999-C1008), Online publication date: 15-Nov-2013. Wang G, Surks H, Tang K, Zhu Y, Mendelsohn M and Blanton R (2013) Steroid-sensitive Gene 1 Is a Novel Cyclic GMP-dependent Protein Kinase I Substrate in Vascular Smooth Muscle Cells, Journal of Biological Chemistry, 10.1074/jbc.M113.456244, 288:34, (24972-24983), Online publication date: 1-Aug-2013. Piwkowska A, Rogacka D, Kasztan M, Angielski S and Jankowski M (2013) Insulin increases glomerular filtration barrier permeability through dimerization of protein kinase G type Iα subunits, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 10.1016/j.bbadis.2013.02.011, 1832:6, (791-804), Online publication date: 1-Jun-2013. Munglue P, Eumkep G, Wray S and Kupittayanant S (2012) The Effects of Watermelon ( Citrullus lanatus ) Extracts and l- Citrulline on Rat Uterine Contractility , Reproductive Sciences, 10.1177/1933719112459223, 20:4, (437-448), Online publication date: 1-Apr-2013. Burgoyne J, Oka S, Ale-Agha N and Eaton P (2013) Hydrogen Peroxide Sensing and Signaling by Protein Kinases in the Cardiovascular System, Antioxidants & Redox Signaling, 10.1089/ars.2012.4817, 18:9, (1042-1052), Online publication date: 20-Mar-2013. Welter H, Kampfer C, Lauf S, Feil R, Schwarzer J, Köhn F and Mayerhofer A (2012) Partial loss of contractile marker proteins in human testicular peritubular cells in infertility patients, Andrology, 10.1111/j.2047-2927.2012.00030.x, 1:2, (318-324), Online publication date: 1-Mar-2013. Chen C, Watson G and Zhao L (2013) Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension, Vascular Pharmacology, 10.1016/j.vph.2012.09.001, 58:3, (211-218), Online publication date: 1-Mar-2013. Kang Y, Kang J and Shin H (2012) Vasodilatory Effects of Cinnamic Acid via the Nitric Oxide-cGMP-PKG Pathway in Rat Thoracic Aorta, Phytotherapy Research, 10.1002/ptr.4708, 27:2, (205-211), Online publication date: 1-Feb-2013. Furuya S and Furuya K (2013) Roles of Substance P and ATP in the Subepithelial Fibroblasts of Rat Intestinal Villi , 10.1016/B978-0-12-407696-9.00003-8, (133-189), . Piwkowska A, Rogacka D, Jankowski M, Kocbuch K and Angielski S (2011) Hydrogen peroxide induces dimerization of protein kinase G type Iα subunits and increases albumin permeability in cultured rat podocytes, Journal of Cellular Physiology, 10.1002/jcp.22810, 227:3, (1004-1016), Online publication date: 1-Mar-2012. Zhang D, Borbouse L, Gebremedhin D, Mendoza S, Zinkevich N, Li R and Gutterman D (2011) H2O2-Induced Dilation in Human Coronary Arterioles: Role of Protein Kinase G Dimerization and Large-Conductance Ca2+-Activated K+ Channel Activation , Circulation Research, 110:3, (471-480), Online publication date: 3-Feb-2012. El-Kadri M, Sharaf-Dabbagh H and Ramsdale D (2010) Role of Antiischemic Agents in the Management of Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS), Cardiovascular Therapeutics, 10.1111/j.1755-5922.2010.00225.x, 30:1, (e16-e22), Online publication date: 1-Feb-2012. Soltan M, Ibrahim E, Tawfek M, Hassan H and Farag F (2011) Raised nitric oxide levels may cause atonic postpartum hemorrhage in women with anemia during pregnancy, International Journal of Gynecology & Obstetrics, 10.1016/j.ijgo.2011.09.017, 116:2, (143-147), Online publication date: 1-Feb-2012. Kang Y, Yang I, Morgan K and Shin H (2012) Cinnamyl alcohol attenuates vasoconstriction by activation of K + channels via NO-cGMP-protein kinase G pathway and inhibition of Rho-kinase , Experimental & Molecular Medicine, 10.3858/emm.2012.44.12.083, 44:12, (749), . Sharma A, Sawhney P, Memisoglu G and Rigby A (2012) Expression, purification, and characterization of coiled coil and leucine zipper domains of C-terminal myosin binding subunit of myosin phosphatase for solution NMR studies, Protein Expression and Purification, 10.1016/j.pep.2011.09.013, 81:1, (126-135), Online publication date: 1-Jan-2012. Wirth A and Offermanns S (2012) G-Protein-Coupled Receptors in Smooth Muscle Muscle, 10.1016/B978-0-12-381510-1.00085-5, (1145-1153), . Freye E (2012) Representative Ailments with Excess Nitric Oxide Formation Acquired Mitochondropathy – A New Paradigm in Western Medicine explaining Chronic Diseases, 10.1007/978-94-007-2036-7_5, (37-53), . Ventura-Martínez R, Rivero-Osorno O, Gómez C and González-Trujano M (2011) Spasmolytic activity of Rosmarinus officinalis L. involves calcium channels in the guinea pig ileum, Journal of Ethnopharmacology, 10.1016/j.jep.2011.08.047, 137:3, (1528-1532), Online publication date: 1-Oct-2011. Arozarena I, Sanchez-Laorden B, Packer L, Hidalgo-Carcedo C, Hayward R, Viros A, Sahai E and Marais R (2011) Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A, Cancer Cell, 10.1016/j.ccr.2010.10.029, 19:1, (45-57), Online publication date: 1-Jan-2011. NamKoong S and Kim Y (2010) Therapeutic Application of Nitric Oxide in Human Diseases, Biomolecules and Therapeutics, 10.4062/biomolther.2010.18.4.351, 18:4, (351-362), Online publication date: 31-Oct-2010. Lavogina D, Nickl C, Enkvist E, Raidaru G, Lust M, Vaasa A, Uri A and Dostmann W (2010) Adenosine analogue–oligo-arginine conjugates (ARCs) serve as high-affinity inhibitors and fluorescence probes of type I cGMP-dependent protein kinase (PKGIα), Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 10.1016/j.bbapap.2010.04.007, 1804:9, (1857-1868), Online publication date: 1-Sep-2010. Khan L, Rosenfeld C, Liu X and Magness R (2010) Regulation of the cGMP-cPKG pathway and large-conductance Ca 2+ -activated K + channels in uterine arteries during the ovine ovarian cycle , American Journal of Physiology-Endocrinology and Metabolism, 10.1152/ajpendo.00375.2009, 298:2, (E222-E228), Online publication date: 1-Feb-2010. Burgoyne J and Eaton P (2010) A Rapid Approach for the Detection, Quantification, and Discovery of Novel Sulfenic Acid or S-Nitrosothiol Modified Proteins Using a Biotin-Switch Method Thiol Redox Transitions in Cell Signaling, Part A: Chemistry and Biochemistry of Low Molecular Weight and Protein Thiols, 10.1016/S0076-6879(10)73015-9, (281-303), . Takimoto E and Kass D (2014) Sildenafil's protective effect against cardiac hypertrophy, Expert Review of Clinical Pharmacology, 10.1586/ecp.09.20, 2:4, (323-327), Online publication date: 1-Jul-2009. Sharma A, Zhou G, Kupferman J, Surks H, Christensen E, Chou J, Mendelsohn M and Rigby A (2008) Probing the Interaction between the Coiled Coil Leucine Zipper of cGMP-dependent Protein Kinase Iα and the C Terminus of the Myosin Binding Subunit of the Myosin Light Chain Phosphatase, Journal of Biological Chemistry, 10.1074/jbc.M804916200, 283:47, (32860-32869), Online publication date: 1-Nov-2008. Sugiura T, Nakanishi H and Roberts J (2008) Proteolytic Processing of cGMP-Dependent Protein Kinase I Mediates Nuclear cGMP Signaling in Vascular Smooth Muscle Cells, Circulation Research, 103:1, (53-60), Online publication date: 3-Jul-2008. November 26, 2007Vol 101, Issue 11 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCRESAHA.107.165779PMID: 18040024 Originally publishedNovember 26, 2007 KeywordsRhoAinositol 1,4,5 triphosphate receptor-associated cGMP kinase substratemyosin phosphatasesmooth musclemyosin phosphatase-rho interacting proteinregulator of G protein signaling 2GMP-dependent protein kinase IPDF download Advertisement